Results 141 to 150 of about 765,759 (204)

Combinational Inhibition of the eIF4F Complex, AKT1, and EZH2 Enhances Anticancer Effects in BRAF^V600E Mutant A375 Melanoma Cells. [PDF]

Oncol Res
Miao Y, Hao F, Ki SH.
europepmc   +1 more source

Mechanisms of chemoresistance in diffuse large B‑cell lymphoma and novel therapeutic strategies (Review). [PDF]

Int J Oncol
Wan M, Wang X, Luo B, Hong H, Zhu Y, Lin T.   +5 more
europepmc   +1 more source

NF-κB activation as a pro-survival signal from pharmacological inhibition of pyruvate dehydrogenase kinase 1 in non-small-cell lung carcinoma cell models. [PDF]

Transl Oncol
Liu Q, Ran M, Shan W, Zhang SL, Tam KY.
europepmc   +1 more source

FOXM1 induces therapy resistance and inhibits apoptosis in a variety of human cancers. [PDF]

Cell Death Dis
Raghuwanshi S, Gartel AL.
europepmc   +1 more source

Decoding SR protein regulation: kinases, phosphatases, and therapeutic targeting strategies. [PDF]

Cell Oncol (Dordr)
Liu N, van der Ende F, van de Water B, Le Dévédec SE.   +3 more
europepmc   +1 more source

Disrupting Akt-Wnt/β-catenin signaling suppresses glioblastoma stem cell growth and tumor progression in immunocompetent mice. [PDF]

J Neurooncol
Sarkar MM, Gonsalves N, Davarzani A, Mitchell E, Singh AM, Karumbaiah L, Stice SL.   +6 more
europepmc   +1 more source

Chicken caspase-3 promotes IBDV replication via the cleavage of IRF7. [PDF]

Front Microbiol
Chen Y, Chen J, Xiang Y, Wei S, Zhao M, Fu K, Li Y, Chen H, Wei P, He X.   +9 more
europepmc   +1 more source

Suppression of miR-195 attenuates oxygen-glucose deprivation/reperfusion-induced BBB destruction, possibly via targeting BCL2L2. [PDF]

Front Neurosci
Dong M, Huang L, Zhang Q, Zhu S, Piao Y, Liu Z.   +5 more
europepmc   +1 more source

Targeting MCL-1 and MAPK overcomes venetoclax resistance in FLT3-ITD-positive AML cells harbouring activating PTPN11 (SHP-2) mutations. [PDF]

Br J Haematol
Fleischmann M, Hansen O, Voigtländer D, Bechwar J, Schwietzer LJ, Bahr S, Schnetzke U, Fischer M, Heidel FH, Schnöder TM, Müller JP, Hochhaus A, Scholl S.   +12 more
europepmc   +1 more source

SHP2 improved Late-onset fetal growth restriction via modulating ROS/BRD4/PI3K/YAP/PIGF signaling induced angiogenesis. [PDF]

PLoS One
Li F, Li Y, Hao W, Zhang X, Shen X, Yang B, Zhang W, Fu L, Gu S.   +8 more
europepmc   +1 more source